ConductScience.org, home

Paper15212156

Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.

Ishida E and 5 others. Pharm Res, 2004. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Papers, record 15212156. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15212156

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
PubMed
Journal
Pharm Res
PubMed
Year
2004
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2026-10-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishida EEmi
2Managit CChittima
3Kawakami SShigeru
4Nishikawa MMakiya
5Yamashita FFumiyoshi
6Hashida MMitsuru

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
EmulsionsMajor topic
GalactoseMajor topic
LiverMajor topic
ProbucolMajor topic
Tissue DistributionMajor topic
Animals
Carbon Radioisotopes
Chemistry, Physical
Cholesterol
Drug Carriers
Egg Yolk
Japan
Liposomes
Mice
Particle Size
Solubility
Soybean Oil
Technology, Pharmaceutical
Tritium

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114559396Targeted and sustained drug delivery using PEGylated galactosylated liposomes.Int J Pharm2003https://conductscience.org/library/papers/14559396PubMed
211728389Synthesis and pharmacological activity of a novel water-soluble hepatocyte-specific polymeric prodrug of prostaglandin E(1) using lactosylated poly(L-glutamic hydrazide) as a carrier.Biochem Pharmacol2001https://conductscience.org/library/papers/11728389PubMed
37829512Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake.J Biol Chem1995https://conductscience.org/library/papers/7829512PubMed
41506642Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication.J Hepatol1992https://conductscience.org/library/papers/1506642PubMed
59215536Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo.J Lipid Res1997https://conductscience.org/library/papers/9215536PubMed
612523658Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.Pharm Res2002https://conductscience.org/library/papers/12523658PubMed
74161471Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.Anal Biochem1966https://conductscience.org/library/papers/4161471PubMed
89685898Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver.J Control Release1998https://conductscience.org/library/papers/9685898PubMed
92820021Hepatic chylomicron remnant (apolipoprotein E) receptors. Their physiologic and clinical importance.Scand J Gastroenterol1987https://conductscience.org/library/papers/2820021PubMed
109635506Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems.Biol Pharm Bull1998https://conductscience.org/library/papers/9635506PubMed
118069549Controlled biodistribution of highly lipophilic drugs with various parenteral formulations.J Drug Target1993https://conductscience.org/library/papers/8069549PubMed
127585037Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B.Nat Med1995https://conductscience.org/library/papers/7585037PubMed
132779654The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.Nature1989https://conductscience.org/library/papers/2779654PubMed
1411770704Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.J Drug Target2001https://conductscience.org/library/papers/11770704PubMed
157664347Lipid microspheres for drug delivery from the pharmaceutical viewpoint.Crit Rev Ther Drug Carrier Syst1994https://conductscience.org/library/papers/7664347PubMed
169500706Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.Hepatology1998https://conductscience.org/library/papers/9500706PubMed
1712174894Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.Anticancer Res2002https://conductscience.org/library/papers/12174894PubMed
186620048The preparation and properties of sterile intravenous emulsions.J Parenter Sci Technol1983https://conductscience.org/library/papers/6620048PubMed
194900611High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.J Cell Biol1969https://conductscience.org/library/papers/4900611PubMed
209630122-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins.Biochemistry1976https://conductscience.org/library/papers/963012PubMed

See all 39 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
26298393Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics.Biomaterials2015https://conductscience.org/library/papers/26298393PubMed
26264646Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.Biomaterials2015https://conductscience.org/library/papers/26264646PubMed
20976577Injectable lipid emulsions-advancements, opportunities and challenges.AAPS PharmSciTech2010https://conductscience.org/library/papers/20976577PubMed
17665288Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice.Pharm Res2008https://conductscience.org/library/papers/17665288PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15212156

GET https://conductscience.org/api/papers/v1/15212156/references?page=2